Gut Microbiome-Derived Metabolites as Biomarkers for Insulin Resistance in Gestational Diabetes
Gestational diabetes mellitus was a major pregnancy complication driven largely by insulin resistance, and its prevalence remained substantial worldwide, affecting about 4 to 16.5% of pregnancies, with a pooled global standardized prevalence of 14.0% in one meta-analytic estimate. This narrative review examined how gut...